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Summary
The mechanisms of adhesion to solid surfaces enable S. mutans to colonize oral cavities and 
form biofilms, which play an important role in caries development. Additional properties 
enabling the survival of S. mutans in the oral cavity include its ability to survive in acidic en-
vironments and specific interactions with other microorganisms inhabiting this ecosystem. 
The aim of this study was to determine the antibacterial activity of saliva histatin-5 (peptide) 
and lysozyme (protein) against S. mutans and L. rhamnosus, as representatives of physiologi-
cal flora.
The study involved strains of physiological (L. rhamnosus) and cariogenic (S. mutans) flora iso-
lated from one patient with diagnosed early caries of the deciduous teeth. 
It was proved that the presence of probiotic L. rhamnosus bacteria in the environment had a 
negative impact on the ability of S. mutans to produce biofilm. Moreover, the antibacterial ac-
tivity of histatin-5 was confirmed, and it inhibited S. mutans growth at concentrations of 27.2 
µg/ml and 54.4 µg/ml, both individually and in a mixture with lysozyme (in a total concen-
tration of 54.4 µg/ml). 
The data obtained constitute a promising result due to their potential future application in 
the prevention and early diagnosis of caries. 
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IntroductIon
S. mutans is a recognized etiological factor of caries [28]. 
The main determinant of S. mutans pathogenicity condi-
tioning its cariogenic character is its biofilm formation 
ability in the oral cavity [20,45]. 
Biofilm formation plays a key role in the etiology of tooth 
and oral cavity diseases, and its formation is a result of 
mutual interactions between the same or different spe-
cies of bacteria. It is thus sensible to determine the ef-
fect of the presence of the non-pathogenic bacterium 
Lactobacillus rhamnosus on the biofilm-forming ability of 
S. mutans.
The growth and development of S. mutans in vivo and in 
vitro depend on several factors such as soil type, pH of 
the environment, available nutrients, and other bacteria 
colonizing the plaque or inhabiting a common ecological 
niche. Increasingly more and more attention is being paid 
to the potential of saliva as a potent anticaries agent. Sa-
liva is a component of the innate immunity of the organ-
ism, which includes a series of antimicrobial proteins such 
as peroxidase, lactoferrin, lysozyme, histatins (HSTs), and 
phospholipases [3].
Histatins
HSTs are a group of neutral and basic proteins rich in the 
amino acid histidine. They are secreted by the parotid and 
sublingual glands in humans [40] and in higher primates 
(macaques) [42], with a broad-spectrum of antibacterial 
activity [8]. Among the 12 protein forms found in saliva, 
the principal ones are HST-1, -3, and -5 [36].
Biological role of histatins
HSTs destabilize the cell membrane of bacteria by binding 
to its surface, which leads to cell damage. Additionally, 
HSTs reduce the release of pro-inflammatory cytokines 
(interleukins, TNFα, metabolites of arachidonic acid, etc.) 
as a response to stimulation of cells with cell wall lipo-
polysaccharide of gram-negative bacteria (during the 
lipid A binding, neutralization and inactivation of lipo-
polysaccharide are observed) [6]. Moreover, the spectrum 
of antimicrobial activity includes microorganisms such as 
S. mutans, S. aureus, P. gingivalis, and E. coli [35].
Antifungal activity of HSTs has also been proven, particu-
larly toward various yeast-like species of the Candida ge-
nus (C. albicans, C. kefyr, C. krusei, C. parapsilosis) and other 
pathogenic species (Cryptococcus neoformans, Aspergillus 
fumigatus) [51]. Fungicidal activity of HSTs is primarily 
associated with permeabilization of mitochondrial and 
cell membranes (binding of HSTs in the form of α-helices 
with membrane sterols, especially with ergosterol, caused 
the formation of channels and leakage of intracellular 
substances and thus cell death) [47].
HSTs bind specifically to membrane receptors and, 
through several mechanisms, induce the production of 
reactive oxygen species (ROS) through the MAPK (mito-
gen-activated protein kinase, mitogen-activated kinase) 
activation mechanism [55], ATP release (through non-
lytic release from cell), inhibition of metabolic pathways 
(cell respiration by mitochondria damage) [12], histamine 
release from mast cells [50], and DNA damage (through 
an ROS-dependent pathway) [31].
HSTs exhibit the ability to bind transition metal ions (Cu2+ 
and Zn2+), which may also be involved in enamel protec-
tion and antimicrobial defense. It has been shown that 
HST-5 is the only protein from the HST group to exhibit 
antiviral activity (toward inhibition of replication of HIV-
1 by the active domain of HST-5 – Dh-5) [57]. It is worth 
noting that despite antimicrobial activity, the above-men-
tioned mechanisms do not lead to the violation of natural 
physiological barrier of the host cells.
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1058
Postepy Hig Med Dosw (online), 2015; tom 69: 1056-1066
Among other features of HSTs, one can distinguish their 
activity as inhibitors of proteolytic enzymes derived from 
microorganisms (metalloprotease, trypsin-like enzymes, 
cysteine protease enzymes) or a host (collagenase) [31]. 
Particularly important is the inhibition of collagenase 
(MMP), for which the activity is increased in pathologi-
cal states and is associated with inflammatory, degenera-
tive diseases and neoplastic processes. Currently, HST is 
considered to be one of the dominant saliva substances 
that play a role in wound healing [4]. HSTs, acting syn-
ergistically with epidermal growth factor (EGF), activate 
G protein-coupled receptors, consequently leading to 
growth and cell migration.
research dIrectIons for hIstatIns
HSTs, as antimicrobial peptides, have a great therapeu-
tic and diagnostic potential in diseases of the oral cavity 
(periodontal disease, candidiasis, oral lichen planus) [7]. 
Their multidirectional activity and safety, compared to 
the host, are key elements of effective therapy. Further-
more, due to their bactericidal and bacteriostatic activi-
ties, these proteins can be used in non-carious bacterial 
diseases (chronic pulmonary infections, cystic fibrosis) 
[31], as well as in viral infections (infection with HIV) [38].
Lysozyme
Lysozyme is a cationic protein, characterized by proper-
ties of hydrolytic enzyme which degrades β-1,4-glycosidic 
bonds in the peptidoglycan structure of bacterial cell 
wall [26]. It can be found in serum, breast milk, tears, and 
saliva, among others, where, together with the compo-
nents of the complement system, it protects the organism 
against infections [29].
Biological role
Lysozyme monomer, i.e., its basic form, exhibits antibac-
terial properties, especially against gram-positive bac-
teria. Lytic activity of lysozyme against gram-negative 
bacteria is reduced due to additional polypeptides and 
lipopolysaccharides present in the structure of the cell 
wall, which constitutes a physical barrier and may in-
activate the enzymes. However, because of the specific 
modifications that lead to the formation of dimers or 
higher order oligomers, lysozyme is capable of extend-
ing the spectrum of its activity [26]. It also has the ability 
to bind to gram-negative bacterial lipopolysaccharides, 
thus contributing to the reduced risk of development of 
an inflammatory response when high quantities of exo-
toxin occur in the organism [9].
Apart from the antibacterial effect, lysozyme also exhibits 
antiviral and antifungal properties, thus opening up the 
possibility of its wider use. An interesting aspect of lyso-
zyme activity is its influence on virulence of Enterococcus 
faecalis. The presence of the enzyme in the host environ-
ment of this microorganism leads to the expression of 
the pathogenicity factor deacetylase, which inhibits the 
activity of the lysozyme itself. Thus, Enterococcus faecalis 
can survive in the host organism either as an opportu-
nistic bacterium or as a pathogen [2].
Biological activity of lysozyme, in combination with proper 
oral hygiene, helps maintain neutral pH in the oral cavity 
and forms the environment in which the ability of cariogenic 
microorganisms toward the formation of biofilm is inhibited 
[10]. The presence of lysozyme in the dental plaque not only 
results in the reduction of the number of cariogenic micro-
organisms in its environment but also leads to a decrease 
in the ability of adhesion of S. mutans to hydroxyapatite [17] 
of tooth enamel. As a result of the reduction of adhesion of 
this microorganism to the surface, simultaneous reduction 
of its biofilm-forming properties is observed.
Our studies showed that lysozyme and HST-5, natu-
rally occurring proteins in the saliva, although they 
do not kill S. mutans bacteria and do not reduce their 
quantity in the oral cavity, impair their ability to at-
tach to the surface of the teeth and prevent the for-
mation of a harmful bacterial layer, which promotes 
the destruction of enamel and caries development. 
These studies are particularly significant in terms of S. 
mutans, because these bacteria can lead to the formation 
of lesions on the condition that it is attached to the tooth 
surface with simultaneous biofilm formation.
Biofilm formation by S. mutans is a complicated and multi-
stage process. The coexistence in the oral cavity of a range 
of appropriate factors and conditions is significant.
1.  An initial phase of microorganism adhesion to a solid 
surface. 
S. mutans adheres to enamel, tooth roots, root cementum 
or dental implants [48] using two mechanisms: saccha-
rose-dependent (based on the activity of glucosyltransfer-
ases, Gtfs and glucan-binding proteins, Gbps) and saccha-
rose-independent (using interactions between adhesive 
particles of microorganisms and saliva agglutinins) [1,30].
2. Formation of an exopolysaccharide matrix [34,58].
3.  Biofilm maturation – stage I. Exopolysaccharide ma-
trix growth.
4. Biofilm maturation – stage II.
Subsequent bacteria species attach to the biofilm (for-
mation of heterogenic aggregates – mixed biofilm) [19]. 
Interactions occurring between the microorganisms, 
mutual influence and microorganism-host interactions, 
where the host immunological system plays a significant 
role [13,18,37].
5. Spread of biofilm-forming bacteria.
It is generally considered that from stage II of biofilm 
formation the inhibition of the formation of its struc-
ture is impossible. This is an example of hyperadditive 
synergism, when an accumulation of the effects of the 
activity of particular biofilm forming species is observed. 
The presence of one microorganism creates ecological 
niches for others, which facilitates their survival in new 
favorable conditions. This phenomenon was defined as 
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co-aggregation by Rickard et al. [39]. An example of such 
interaction is lactate secretion by streptococci-forming 
biofilm, which becomes the source of carbon for Candida 
albicans. The growth of C. albicans reduces the availabil-
ity of oxygen to the level preferred by streptococci, thus 
stimulating their growth [5]. 
The bacteria in biofilm are always metabolically active, 
which involves changes in pH and loss of tooth enamel 
hydroxyapatites, finally leading to the dissolution of hard 
tooth tissues and the formation of caries and cavities [25]. 
The multiplicity of inter-species interactions in biofilm 
engaged in the pathogenesis process of diseases such as 
caries means that not all of them are obvious. There are 
examples of clinical cases described in the literature of 
clinical cases which prove that bacterial translocation 
from the oral cavity to remote organs may contribute 
to the development of diseases such as coronary disease 
[22]. Recognition of dental plaque formation mechanisms 
is thus important both from the point of view of oral cav-
ity health protection, and also from that of general health 
status. Thus it is important to recognize connections be-
tween oral cavity bacteria and various systemic diseases 
[32,44]. Biofilm formation is the main factor determining 
the pathogenicity of numerous bacteria, and the inhibi-
tion of this process may be a potential method of disease 
treatment. The key issue for a better understanding of 
the significance of interactions between biofilm forming 
microorganisms and caries development is the determi-
nation of the details of mutual signaling in coexistence 
conditions and the identification of molecular processes 
engaged in biofilm formation. Characterization of biologi-
cal activity at protein and cell levels will allow the design 
of drugs inhibiting the metabolism of bacteria accumu-
lated in biofilm structures. These activities would allow 
the development of methods and techniques enabling 
an analysis of the anti-biofilm activity of the drug par-
ticles and be significant in commercialization of innova-
tive chemical structures which may become candidates 
for drugs. 
Examples of biofilm forming inhibition as a therapeutic 
strategy in caries prevention were extensively described 
in our previous review paper [20].
aIm of the study
The aim of this study was to determine the antibacterial 
activity of histatin-5 and lysozyme against S. mutans and 
L. rhamnosus.
materIals and methods
Examined group and healthy volunteers
The study included pure cultures of two clinical strains 
isolated from one patient (boy) with diagnosed early 
childhood caries (ECC; dmft score: 5.2) of the deciduous 
teeth (n = 1; age: 4 years), treated at the Department of 
Pediatric Dentistry, Institute of Dentistry, Jagiellonian 
University Medical College, Krakow, Poland. The suitabil-
ity of the patient for the study was confirmed by a dentist 
during a routine dental examination. The research mate-
rial was carious foci in teeth of a child patient with caries 
taking part in the experiment. Factors excluding partici-
pation in the study were insufficiently developed chewing 
activity observed in small children and mentally disabled 
patients, and the lack of consent from the child’s guard-
ians for their children’s participation in the experiment. 
Unstimulated saliva was isolated from healthy volunteers 
(n=10, age: 5±1.5 years) without carious lesions of decidu-
ous teeth, who were kept under the clinic’s control.
The classification of patients for the study was performed 
by a qualified dentist during a routine dental examina-
tion. Dental examinations were based on WHO recom-
mendations for the diagnosis of Early Childhood Caries 
(ECC), International Caries Detection and Assessment Sys-
tem (ICDAS) II and under artificial lighting using a den-
tal mirror (Kavo Lux 1415, Germany) and a periodontal 
probe (WHO LM 8-550 B XSI, LM, USA). The legal guard-
ians of the participants of the study were fully informed 
about its aim and course, and agreed on their children’s 
participation.
Material collection
After acceptance of the patient for the research, scrap-
ings from carious foci were collected for examination 
using an open system composed of a sterile cotton swab 
placed in a test tube. The patient maintained a fasting 
status, and sampling was performed between 8 and 10 
a.m. after prior oral cavity rinsing with distilled water. 
Once collected, the material was sealed in sterile test 
tubes, protected from oxygen, and transported at room 
temperature to the laboratory within a time period of no 
longer than 2 hours.
Culture of collected material
The clinical material was immediately inoculated on a 
selective medium (HLR-S). The range of inhibition of the 
growth of bacteria colonizing an oral cavity was verified 
in a preliminary study on four media which are described 
in the literature as selective for this group of pathogens 
[21,56]. 
S. mutans ATCC 25175 and L. rhamnosus ATCC 7469 (Ameri-
can Type Cell Culture, USA) strains, cultured on brain 
heart infusion broth medium (BHI, TCS Bioscience Ltd, 
USA), were used as reference standards.
In order to examine biofilm formation, clinical strains of 
S. mutans, L. rhamnosus in single cultures and S. mutans in 
mixed culture with L. rhamnosus were grown in 12-well 
polystyrene flat-bottom plates in BHI medium supple-
mented with the addition of 3% saccharose, according 
to the method described by Lee et al. [24].
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Bacterial identification
Phenotyping of clinical isolates of S. mutans and L. rham-
nosus.
Enzymatic typing was performed based on the enzymatic 
profiles obtained from the STREPTOtest 24 test (Lachema, 
Pliva, Czech Republic) according to the manufacturer’s 
instructions.
Preparation of histatin-5 and lysozyme solutions
Histatin-5 and lysozyme (No.: H6027, No.: L6876, Sigma-Al-
drich Co. St. Louis, MO, USA) were dissolved with Nuclease-
Free Water (Ambion, USA) to a final concentration of 0.1 mM.
Antibacterial activity of selected peptides against 
S. mutans and L. rhamnosus
The susceptibility of S. mutans and L. rhamnosus clinical 
strains for selected peptides was determined according to 
the method elaborated by the Clinical Laboratory Standard 
Institute (CLSI, 2012). Freshly passaged strains were suspend-
ed in tryptic soy agar (TSA; BD Bioscience, USA) and left until 
the next day to allow proliferation. The number of colonies 
was determined by culturing 10 µl of bacterial suspension 
on solid TSA medium. An initial bacteria concentration of 
2.5×106 cells/ml was prepared in fresh TSA medium. 160 µl 
of fresh TSA medium was applied to each well of a 96-well 
plate (Plaque MICROTEST, Becton Dickinson, USA). In the 
next stage, pre-prepared solutions of histatin-5 and lyso-
zyme were added to the last wells of each row of a 96-well 
plate, and serial dilutions were performed using a multi-
channel pipette by moving to the next (11,10,9,8,..1) wells, 
thus obtaining a range of concentrations for the histatin-5 
and lysozyme: 0.85-218 µg/ml. In the next stage, the wells 
of a 96-well plate previously covered with the histatin-5 
and lysozyme were inoculated with 10 µl of bacterial sus-
pension (4×105 cells; 0.5 McFarland’s) and incubated at a 
temperature of 37ºC in anaerobic conditions until the next 
day. Bacteria growth was measured spectrophotometrically 
on a plate reader (EnSpire Multimode Plate Readers, Perkin 
Elmer, USA) with a wavelength of 660 nm. The minimum in-
hibiting concentration for bacteria was determined as the 
lowest protein concentration of the protein which entirely 
inhibited the growth of bacteria.
Plate preparation for biofilm examination 
Stimulated saliva from healthy volunteers was collected 
using Salivette (Sarstedt, Germany) cotton and synthetic 
swabs. The swabs were placed inside the participants’ 
mouths and they were asked to chew on these pads for 
50 s to stimulate saliva. The stimulated saliva was col-
lected from the swabs by centrifugation at 10000×g for 15 
min at 4°C. Supernatant collected after centrifugation was 
passed through a filter with a pore diameter of 0.22 μm 
(PVDF, ROTH, Germany) in sterile conditions. The amount 
of 100 μl of saliva was introduced to each well of a 12-well 
plate (SPL, Lifescience, USA). The plates were incubated 
for 60 minutes at a temperature of 4°C.
S. mutans and L. rhamnosus biofilm – stage of 
adhesion and formation
S. mutans and L. rhamnosus strains were incubated in BHI 
medium at 37°C in aerobic conditions overnight, and then 
they were used for inoculation of fresh BHI medium sup-
plemented with 3% and 0.25% saccharose. In order to 
evaluate biofilm formation by S. mutans and L. rhamnosus, 
a previously prepared 12-well plate was inoculated with 
bacterial suspension (10 µl of an individual species and 5 
µl of each strain in mixed culture) and was incubated at 
37°C in anaerobic conditions for 72 hours. The medium 
was replaced each day with BHI, containing 3% and 0.25% 
saccharose. Any biofilm formed was rinsed three times 
with PBS solution in order to remove planktonic forms 
of S. mutans, L. rhamnosus, and the co-culture of S. mutans 
and L. rhamnosus, and a the solutions of examined peptides 
were added: histatin-5 (final concentration 54.4 µg/ml), 
lysozyme (final concentration 54.4 µg/ml) and a mixture: 
histatin-5 with lysozyme (in the combined concentration 
54.4 µg/ml) in a volume of 10 μl each for 15 minutes. Af-
ter removal of the histatin-5 and lysozyme suspension, 
the biofilm was rinsed three times with PBS, and then 
mixed with 1 ml of BHI medium. The formed biofilm was 
physically separated from the medium using small cell 
scrapers (Corning Co, USA) and transferred to 1.5 ml test 
tubes. The cells were homogenized for 1 min, and serial 
dilutions were prepared in a range from 10 to 106 in TSB 
medium. Next, 50 µl of bacterial suspension from each 
dilution was inoculated on MSB medium (Mitis-salivarius 
bacitracin agar, BD Bioscience, USA) and incubated at 37°C 
for 36 h. The resulting S. mutans and L. rhamnosus colonies 
were counted to obtain 5 × 106 CFU. In order to analyze 
the formed biofilm and inhibition of its formation, the 
biofilm was rinsed three times in PBS and stained using 
a water solution of safranin (0.25%) and ethanol (0.5%). 
Dye solution was siphoned off and the wells were rinsed a 
few times with PBS. Absorbance was measured at a wave-
length of 492 nm. PBS was siphoned off. The plates were 
air dried for 1 hour. 70% ethanol was added to the wells 
and destained for 45 min. 100 μl of the content of the 
wells was transferred to the new plate wells. Absorbance 
measurement was performed at a wavelength of 492 nm.
Statistical analysis
Values were expressed as means ± SD. Student t test and one-
way analysis of variance (*p <0.05<**p<0.01<***p<0.001) 
followed by Tukey post hoc tests were used to determine 
significant differences between samples.
results 
Susceptibility of S. mutans and L. rhamnosus to 
histatin-5 and lysozyme
The susceptibility test demonstrated that histatin-5, ly-
sozyme and a mixture of the examined compounds in-
hibited the growth of S. mutans clinical strains at concen-
trations of 27.2 µg/ml and 54.4 µg/ml (Fig. 1). However, 
1061
Krzyściak W. et al. – Effect of histatin-5 and lysozyme...
the above-mentioned concentrations of histatin-5 and 
lysozyme demonstrated a different antibacterial activ-
ity towards the L. rhamnosus clinical strain. Additionally, 
it was observed that the mixture of histatin-5 and lyso-
zyme exhibited a synergistic effect inhibiting L. rhamnosus 
growth at a final concentrations of 27.2 µg/ml and 54.4 
µg/ml of each peptide. In turn, the decreases growth of 
L. rhamnosus was noted only at a concentration of 54.48 
µg/ml (Fig. 2). Similarly, lysozyme inhibited L. rhamnosus 
growth at a concentration of 54.4 µg/ml (Fig. 2). Interest-
ingly, histatin-5 inhibited the growth of clinical strains 
of L. rhamnosus at concentrations of 27.2 µg/ml and 54.48 
µg/ml (Fig. 2).
Anti-biofilm-forming activity of histatin-5 and 
lysozyme
Solutions of histatin-5 and lysozyme in two selected 
concentrations – 27.2 µg/ml and/or 54.4 µg/ml – were 
introduced to biofilm formed by S. mutans on a 12-well 
polystyrene plate, and then inoculated in plates with BHI 
medium enriched with 3% saccharose. Antibacterial ef-
fectiveness against both S. mutans and L. rhamnosus was 
demonstrated for the peptide mixture at the concentra-
tion of 54.4 µg/ml (in total), while separately histatin-5 
and lysozyme demonstrated an anti-biofilm forming ac-
tivity against S. mutans at a concentration of 54.4 µg/ml. 
In order to determine whether the observed differ-
ences in CFU number were a result of the bactericidal 
activity of the examined peptides or biofilm removal, 
a spectrophotometric analysis of organisms accumu-
lated in the biofilm structure was performed using 
the safranin staining method, which is presented in 
figures 3-4. The highest anti-biofilm-forming activ-
ity was demonstrated for His-5 at a concentration of 
54.4 µg/ml, lysozyme at a concentration of 54.4 µg/ml, 
His-5 combined with lysozyme at a total concentration 
of 54.4 µg/ml, which was visible after 60 h of incuba-
tion for single cultures of S. mutans, and L. rhamnosus 
and double culture just after 48 h of incubation of S. 
mutans/L. rhamnosus (Fig. 5). The activity of lysozyme 
showed statistically significant differences in inhibi-
tion of biofilm formation both against single cultures 
of S. mutans and L. rhamnosus as well as in the coculture 
of S. mutans and L. rhamnosus (Fig. 6, 7).
 
Fig. 1.  Susceptibility of S. mutans (ATCC 25175 and clinical) to histatin-5, 
lysozyme and examined peptides (histatin-5 and lysozyme 
together) in 10 different concentrations: 0.85 μg/ml; 
1.7 μg/ml; 3.4 μg/ml; 6.8 μg/ml; 13.6 μg/ml; 27.2 μg/ml; 54.4 μg/
ml; 108.8 μg/ml; 217.6 μg/ml and 435.2 μg/ml. Experiments were 
conducted in triplicate in two individuals, and expressed as mean 
± standard deviation. Statistically significant values were marked 
for concentrations: 27.2 #p=0.03; 54.4 ##p=0.004 and for the 
concentration of 108.9 ###p=0.0001 (after histatin, lysozyme and 
examined peptide mixture, respectively), compared to untreated 
control bacteria (without examined peptide addition [0.0 μg/ml]). 
In the case of S. mutans cell lines treated with the examined peptide 
mixture, a statistically significant difference was noted starting from 
the concentration of 54.4 *p=0.04 (alpha accepted for critical ranges 
= 0.05; Tukey’s test). SM ATCC25175 – standard strain of pure S. mutans 
colonies; SM – control, S. mutans colonies cultured from one patient; 
SMh – S. mutans bacteria treated with histatin-5 solution; SMl – S. 
mutans bacteria treated with lysozyme solution, SMh+l – S. mutans 
bacteria treated with solution of histatin-5 and lysozyme
 
Fig. 2.  Susceptibility of L. rhamnosus (ATCC 7469 and clinical) to histatin-5, 
lysozyme and examined peptides (histatin-5 and lysozyme together) in 10 
different concentrations: 0.85 μg/ml; 1.7 μg/ml; 3.4 μg/ml; 6.8 
μg/ml; 13.6 μg/ml; 27.2 μg/ml; 54.4 μg/ml; 108.8 μg/ml; 217.6 μg/ml and 
435.2 μg/ml. Experiments were conducted in triplicate on two individuals, 
and expressed as mean ± standard deviation. A statistically significant 
value in the case of histatin was marked for concentrations: 27.2; 54.4 µg/
ml #p<0.01; and for the concentration of 108.9 ##p<0.002, compared 
to untreated control bacteria (without the addition of the examined 
peptides [0.0 μg/ml]). In the case of L. rhamnosus cell lines treated with 
the examined peptide mixture, a statistically significant difference was 
noted starting from the concentration of 54.4 *p=0.01. In the case of 
lysozyme, a statistically significant difference was noted starting from 
the concentration of 54.4 *p=0.03 and 108.8 **p=0.004. LR ATCC7469 – 
standard strain of pure L. rhamnosus colonies; LR – control, L. rhamnosus 
colonies cultured from one patient; LRh – L. rhamnosus bacteria treated 
with histatin-5 solution; LRl – L. rhamnosus bacteria treated with lysozyme 
solution, LRh+l – L. rhamnosus bacteria treated with a solution of histatin-5 
and lysozyme.
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Fig. 3.  The effect of the examined peptides on the ability of biofilm formation 
by S. mutans. The data presented are expressed as mean and standard 
deviation. Statistically significant differences are expressed as 
***p<0.00001< **p< 0.0001 compared to untreated control S. 
mutans bacteria. SM – S. mutans clinical strain (control for particular 
concentrations 1 and 2); SM h – S. mutans clinical strain after histatin-5 
(1 mM) in two examined concentrations (1, 2); SM l – S. mutans clinical 
strain after lysozyme (1 mM) in two examined concentrations (1, 2); 
SM h+l – S. mutans clinical strain after histatin-5 (1 mM) and lysozyme 
(1 mM) in two examined concentrations (1, 2). Colony-forming unit 
(CFU) is a rough estimate of the number of viable bacteria in a sample. 
The results are reported as CFU/mL (colony-forming units per milliliter) 
for liquid medium
 
Fig. 5.  Biofilm formation by S. mutans in single and double culture with L. 
rhamnosus affected by histatin-5 (54.4 µg/ml). The data presented 
are expressed as mean and standard deviation. Statistically significant 
differences are expressed as *p<0.04<** 0.005<***0.00006 compared 
to absorbance values after 12 hours of incubation
 
Fig. 6.  Biofilm formation by S. mutans in single and double culture with L. 
rhamnosus affected by lysozyme (54.4 µg/ml). The data presented are 
expressed as mean and standard deviation. Statistically significant 
differences are expressed as *p<0.05<**p<0.006<***p<0.00005 
compared to absorbance values after 12 hours of incubation.  
 
Fig. 7.  Biofilm formation by S. mutans in single and double culture with L. rhamnosus 
affected by the examined peptide mixture: histatin-5 and lysozyme (total 
concentration 54.4 µg/ml). The data presented are expressed as mean and 
standard deviation. Statistically significant differences are expressed as *p 
<0.02<**p<0.002<***p<0.00002 compared to absorbance values after 12 
hours of incubation
 
Fig. 4.  The effect of the examined peptides on the ability of biofilm formation 
by L. rhamnosus. The data presented are expressed as mean and 
standard deviation. The statistically significant differences are expressed 
as **p <0.01 compared to untreated control L. rhamnosus bacteria. LR 
– L. rhamnosus clinical strain in two examined concentrations (1-2); LR 
h – L. rhamnosus clinical strain after histatin-5 (1 mM) in two examined 
concentrations (1-2); LR l – L. rhamnosus clinical strain after lysozyme 
(1 mM) in two examined concentrations (1-2); LR h+l – L. rhamnosus 
after histatin-5 (1 mM) and lysozyme (1 mM) in two examined 
concentrations (1-2). Colony-forming unit (CFU) is a rough estimate of 
the number of viable bacteria in a sample. The results are reported as 
CFU/mL (colony-forming units per milliliter) for liquid medium
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dIscussIon
It was possible to notice differences in biofilm-forming 
ability between separate cultures of S. mutans and L. rham-
nosus and combined cultures in BHI medium with 3% sac-
charose. The highest biofilm-forming ability was noted 
for pure S. mutans cultures, for which absorbance mea-
sured after 72 hours of incubation was 0.428±0.003 on 
average. After the same time for Lactobacillus culture this 
was 0.324±0.005 on average, i.e. nearly 75% less. Lower ab-
sorbance may prove lower amounts of microorganisms 
accumulated in biofilm structures. Moreover, an inhibit-
ing effect of L. rhamnosus on biofilm formation by S. mu-
tans was observed in double cultures, which is consistent 
with the results obtained by Teanpaisan et al. (2011) [54]. 
Unfortunately, the mechanism of interactions between 
the microorganisms Lactobacillus and S. mutans has not 
been fully examined so far. 
The role of Lactobacillus bacteria in the maintenance of 
oral cavity hygiene is also a result of their co-aggregation 
with S. mutans cells. This relationship concerns L. paracasei 
and L. rhamnosus [23]. The combination of physiological 
flora microorganisms with species of potentially cario-
genic character in the form of aggregates inhibits the 
adhesive properties of S. mutans regarding teeth surfaces 
and gums, thus inhibiting the process of cariogenesis. 
Therefore, the pathogen may be removed from the oral 
cavity together with saliva before the onset of the first 
stage of biofilm formation [23].
Interactions observed between S. mutans and other micro-
organisms inhabiting the oral cavity may both favor and 
inhibit biofilm formation. It is important to use the exten-
sive potential of natural rather than synthetic compounds, 
such as probiotics of specific antibacterial proteins. These 
substances exhibit a considerably lower number of side 
effects compared to preparations obtained synthetically, 
and are adopted for an activity in specific environment 
conditions, which allows the maintenance of high levels 
of activity of these preparations over a long time.
The group of twelve cationic histidine proteins present 
in saliva is mainly represented by histatin-1, -3 and -5, 
which demonstrate very high antibacterial and antifun-
gal activity [8,15]. The most abundant, histatin-5 (His-5), 
is primarily known for its antifungal properties, dem-
onstrated especially towards C. albicans and C. glabrata 
[27,51]. It has been demonstrated that the biocidal ac-
tivity of His-5 also includes bacteria such as S. mutans, S. 
mitis and Porphyromonas gingivalis [53]. 
So far, the susceptibility of biofilm formation by oral bac-
teria to the combination of histatin-5 and lysozyme has 
not been examined. There are numerous works evaluat-
ing the antimicrobial activity of single peptides, includ-
ing histatin-5. 
The effect of histatin-5 on the biofilm formation ability 
of S. mutans was studied by Helmerhorst et al. [11]. The 
authors evaluated the effect of synthetic histatin equiva-
lents on a dental plaque model formed from 7 bacteria 
species commonly observed in the oral cavity. These mi-
croorganisms included S. mutans, S. sanguis, S. salivarius, 
Actinomyces naeslundii, Veillonella parvula, Fusobacterium 
nucleatum and Prevotella intermedia. The peptides applied 
(Dhvar3 and Dhvar4) were histatin-5 analogs of a widened 
spectrum of antibacterial activity compared to natural 
forms of proteins. Ex situ examinations demonstrated that 
the synthetic proteins Dhvar3 and Dhvar4 act ca. 10-fold 
more effectively, thus reducing the number of microor-
ganisms in biofilm, compared to natural histatin. S. mu-
tans accumulated in biofilm demonstrated susceptibility 
to histatin-5 at a concentration of 100 µg/ml, which is 
consistent with our results demonstrating the effective-
ness of 54.4 µg of His-5/ml (i.e. 18.13 µM).
The effect of histatin-5 on S. mutans growth was also 
examined by Huo et al. [14]. They used peptide P-113, 
which is the shortest fragment of the His-5 protein (com-
posed of 12 amino acids) maintaining antibacterial ac-
tivity comparable to the activity of a full chain length 
protein. The MIC of peptide P-113 for the reference strain 
S. mutans UA 159 was 27.29 µM on average. The inhibit-
ing activity of P-113 on the growth of S. mutans was vis-
ible after 10-hour incubation, while the strain UA 159, 
cultured without peptide addition, exhibited an increas-
ing tendency for the whole time period. The activity of 
the peptide at a concentration of 27.29 µM was compa-
rable to the activity of 1.60 µM of chlorhexidine, which 
showed equal growth inhibition of this microorganism 
after 4 hours. After incubation with peptide P-113, no 
lysed bacterial cells were detected, which confirms that 
histidine-5 induces changes in the intracellular activity 
of the microorganism without disturbing the membrane 
integrity [14]. This research is consistent with the results 
obtained in this study, where an enhancement of the ef-
fect of natural antibacterial peptide activity via the com-
bination at suitable selected concentrations was demon-
strated. This can indicate a new direction for research 
on bacterial biofilms. An advantage of our research is 
the fact that the activity of natural proteins may be en-
hanced without the use of synthetic derivatives, assum-
ing that a suitable combination at an appropriate con-
centration is applied.
Apart from histatins, healthy human saliva additionally 
contains many other factors constituting a defense sys-
tem against various infections. These include lactoferrin, 
salivary peroxidase systems, immunoglobulins, growth 
factors and lysozyme. Their activity combined with suit-
able oral cavity hygiene helps to maintain oral cavity neu-
tral pH and forms an environment in which the ability of 
cariogenic microorganisms to form biofilm is inhibited 
[10]. We evaluated the activity of the combination of pep-
tide His-5 and lysozyme on both the bacteria S. mutans and 
L. rhamnosus and a combined culture of these microorgan-
isms. The results of our study showed that lysozyme alone 
inhibited the biofilm-forming ability of S mutans and L. 
rhamnosus [Fig. 3,4]. The literature describes the effect of 
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lysozyme on the ability of S. mutans to adhere to the tooth 
surface. After the addition of this protein, not only a de-
crease in the number of cariogenic microorganisms, but 
also a decrease of S. mutans adhesive properties towards 
teeth enamel hydroxyapatite was observed in the dental 
plaque [17]. Lowered adhesion of this microorganism to 
the teeth surface results in a concurrent decrease in its 
biofilm-forming properties. A study concerning the mu-
tual effect of lysozyme and glucosyltransferase B (GtfB) 
from S. mutans on its activity in solution and in a form 
related to hydroxyapatite (HA) was performed by the 
team of Kho and co-workers [17]. This effect seems to be 
related to biofilm-forming properties of S. mutans due to 
the GtfB activity. This enzyme converts sugars that oc-
cur in foods, mainly saccharose, to water-insoluble glu-
cans, enabling the adhesion of many microorganisms to 
biofilm structures. The authors demonstrated that the 
specific activity of lysozyme in saliva solution is 10-15-
fold higher than in a form bound to HA. The difference in 
these activities may also be observed between lysozyme 
derived from human saliva and hen egg white, the activity 
of hen enzyme showing significant superiority over the 
human one. The study also demonstrated that the pres-
ence of GtfB does not significantly affect the activity of 
any of the above-mentioned lysozymes either in liquid or 
in bound phase. That situation varies in the case of the 
influence of lysozyme activity on GtfB. Saliva containing 
glucosyltransferase with removed antibacterial protein 
was used for evaluation of the effect of lysozyme on GtfB 
in solution. Such prepared saliva demonstrated consider-
ably higher activity of bacterial enzymes compared to the 
normal saliva samples, which unequivocally shows the 
inhibiting potential of lysozyme towards GtfB. Thus it is 
supposed that lysozyme, which decreases the activity of 
enzymes essential for biofilm formation, would decrease 
the biofilm-forming ability of S. mutans. Glucan formation 
by GtfB was also analyzed in a model where lysozyme was 
bound to the HA surface. In this case, the amount of glu-
cans formed appeared to be 3-fold lower than in the case 
of lysozyme activity in a solution. The results of the study 
by Huo et al. [14] confirm the negative effect of lysozyme 
on S. mutans biofilm-forming ability by the changes in 
GtfB functioning, and as a result also in the exopolysac-
charide matrix. The results of our study confirmed the 
role of lysozyme described in the literature, and focused 
our attention on the synergistic activity of both pep-
tides. The combination of lysozyme and histatin-5 in a 
total concentration of 54.4 µg/ml inhibited the ability of 
biofilm formation both in individual cultures of S. mutans 
and in mixed cultures of S. mutans and L. rhamnosus [Fig. 
7] after 60 of incubation. 
Apart from antibacterial activity, lysozyme is known for 
its antifungal effects towards yeast-like fungi of the Can-
dida genus [9,43]. Its effect on biofilm formed by these mi-
croorganisms has been evaluated by using kinetic biofilm 
measurements, scanning electron microscopy and laser 
confocal microscopy [43]. These studies demonstrated 
that lysozyme at a physiological concentration in saliva 
(1-57 µg/ml) is sufficient for effective inhibition of bio-
film formation by C. albicans. These results are consistent 
with the results of Roger et al. [41], who demonstrated 
that lysozyme successfully inhibits the biofilm forma-
tion by S. mutans at concentrations of 50-200 µg/ml [46].
The activity exhibited by lysozyme may be compared to 
the activity of lactoferrin, which at a concentration of 
20 µg/ml inhibited the growth and biofilm formation by 
this microorganism [10].
The inhibitory activity of saliva components such as ly-
sozyme, saliva peroxidase systems and immunoglobulins 
towards dental plaque formation was confirmed in the 
studies of Hatti [10]. They demonstrated that application 
of paste containing the above-mentioned elements may 
inhibit dental plaque formation. The dental plaque index 
was calculated for the experiment participants before the 
test and after 4 days of paste application.
Comparing the antibacterial activity of both proteins after 
48 of incubation, anti-biofilm forming effectiveness at a con-
centration of 54.4 µg/ml was demonstrated for His-5 (Fig. 5), 
while after 60 hours of incubation lysozyme also inhibited 
the biofilm formation by S. mutans, and L. rhamnosus and 
mixed culture of S. mutans and L. rhamnosus (Fig. 6). How-
ever, the mechanism of growth inhibition and bacterial cell 
death differs between histatin-5 and lysozyme. The results 
obtained prompt further research on their application as 
potential particles to combat oral cavity microorganisms.
It is interesting that lysozyme has recently been used as 
a substrate for transporting protein nanoparticles [33]. 
With the suitable combination of the lysozyme with the 
polymethacrylate matrix and the specific modification 
of cellulose, it was possible to obtain nanoparticles from 
which antibacterial protein is released gradually for 4 h. 
This combination provides numerous possibilities which 
may be used e.g. in dental materials. 
The determination of individual genetic differences 
concerning the expression of particular saliva proteins 
proved that individuals with a higher number of mRNA 
gene copies for β-defensin-2 (HBD-2) reveal a higher 
degree of resistance to caries. HBD-1 is subject to con-
stitutive expression in the presence of commensal mi-
croorganisms, while HBD-2 and HBD-3 are induced by ex-
ogenous pathogens. HBD-2 is to a higher degree induced 
by pro-inflammatory factors, while HBD-1 and HBD-3 
are to a higher degree induced by microorganism cell 
components [16].
Advances in understanding of the properties of human 
saliva protein composition and the research combining 
the activity of selected antimicrobial peptides with their 
inhibitory effect on cariogenic flora will enable an elabo-
ration of those natural compounds which may effectively 
be used on a wide scale in materials for dental fillings and 
oral cavity hygiene, which may decrease cases of diseases 
related not only to the cariogenic activity of S. mutans, but 
also other microorganisms.
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